Beijing Enterprises Medical and Health Industry Group Limited provided preliminary group earnings guidance for the six months ended June 30, 2018. For the six months, the Board anticipates that the Group will record a significant decrease of loss for the current period compared to the loss for the six months ended 30 June 2017 of the Group. Such change is mainly due to the combined effect of followings: Benefiting from the favorable development of the general health market in the People's Republic of China, the revenue and the gross profit of the Group increased by 67% and 73% respectively, compared to that of the same period of last year; The Group recorded a net gain of HKD 15,000,000 from disposal of a non-wholly owned subsidiary with net liability during the current period; Interest income increased by HKD 16,900,000 compared to that of the same period of last year, generated from the loans the company lent as a strategic planning for idle funds; and Based on the preliminary valuation report of investment properties provided by the company’s valuer, the total fair value gain of the Group's investment properties in Shanghai and Beijing increased no less than HKD 71,000,000 compared to that of the same period of last year.